|
⚲
|
| Keyboard |
| Quantum Cyber NV
✚
|
|
|---|---|
| CIK # | 0001874252 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001874252] | |
| 10-Q | [0001874252] | |
| 3 | [0001874252] | |
| 4 | [0001874252] | |
| 6-K | [0001874252] | |
| 8-K | [0001874252] | |
| D | [0001874252] | |
| SC 13D | [0001874252] | |
| SC 13G | [0001874252] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Lazar David E | Quantum Cyber NV | [2026-04-28] |
| Donahue Kevin Michael | Mainz Biomed NV | [2026-01-16] |
| Armistice Capital LLC | Mainz Biomed NV | [2025-02-14] |
| KFW | Mainz Biomed NV | [2023-03-01] |
| Hekland Hans | Mainz Biomed NV | [2022-05-16] |
| Eidens Moritz | Mainz Biomed NV | [2022-05-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mainz Biomed NV | |
| O'Rourke Peter | |
| Ben-Tzvi Avraham | |
| Natan David | |
| Lazar David E | |
| Dreismann Heinrich | |
| Hekland Hans | |
| Baechler Guido | |
| Tibbitts Gregory J | |
| Caragol William J | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mainz Biomed NV MYNZ
Series A Preferred Shares · derivative
|
2026-02-13 | Grant | 1,000,000 | ||
|
Mainz Biomed NV MYNZ
Series B Preferred Shares · derivative
|
2026-02-13 | Grant | 1,000,000 | ||
|
Mainz Biomed NV MYNZ
Series C Preferred Shares · derivative
|
2026-02-13 | Grant | 1,000,000 | ||
|
Mainz Biomed NV MYNZ
Ordinary Shares
|
2026-02-13 | Grant | 440,000 | $0.00 | |
|
Mainz Biomed NV MYNZ
Ordinary Shares
|
2026-02-13 | Grant | 45,000 | $0.00 | |
|
Mainz Biomed NV MYNZ
Ordinary Shares
|
2026-02-13 | Grant | 45,000 | $0.00 | |
|
Mainz Biomed NV MYNZ
Ordinary Shares
|
2026-02-13 | Grant | 290,000 | $0.00 | |
|
Mainz Biomed NV MYNZ
Common Stock
|
2025-10-17 | Buy | 643,850 | $402,000.00 | 258,827,700,000 |